Ian Guldner Joins Salk Institute to Propel Breakthrough Research on Brain Aging and Alzheimer’s Disease
The Salk Institute has announced a significant expansion to its faculty roster with the appointment of Dr. Ian Guldner, a ...
Tag: therapeutic targets for Alzheimer’s
Tubulin Combats Neurodegeneration by Blocking Toxic Protein Aggregates in the Brain
In a groundbreaking advancement in neurodegenerative disease research, scientists at Baylor College of Medicine have uncovered a promising new mechanism ...
New Protein Interaction Map Uncovers Mechanisms Behind Disrupted Brain Cell Communication in Alzheimer’s Disease
A groundbreaking study from the Icahn School of Medicine at Mount Sinai has unveiled an unprecedentedly detailed map of brain ...
Mir-199a-3p Fuels Neuroinflammation in Alzheimer’s Model
In the ever-evolving landscape of neurodegenerative disease research, a breakthrough study has emerged, highlighting the intricate interplay between microglial polarization ...
Complement C1q Links Amyloid-β and Tau in Alzheimer’s
In a groundbreaking advancement in Alzheimer’s disease research, scientists have uncovered a pivotal role of the complement protein C1q in ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!